Table 2. Hazard ratios (HR) and 95% confidence intervals (95% CI) for associations between baseline C-reactive protein and interleukin-6 concentrations (by quartiles) and prostate cancer risk¹.

	No. Cases/cohort	Total Person-Years	HR2	95% CI2
CRP (mg/l)
<1.10	46	4673	1.00	Ref
1.10-2.11	59	4572	1.27	0.86-1.87
2.11-3.47	55	4332	1.29	0.87-1.91
>3.47	42	4024	1.03	0.67-1.57
Log(CRP)			1.02	0.85-1.21
IL-6 (mg/l)
<1.23	51	4668	1.00	Ref
1.23-1.69	57	4256	1.24	0.84-1.83
1.69-2.47	45	3800	1.17	0.78-1.76
>2.47	32	3624	0.90	0.57-1.40
Log(IL-6)			0.97	0.74-1.27
Excluding cases diagnosed in first 5 years
CRP (mg/l)
<1.10	17	4107	1.00	Ref
1.10-2.11	25	4188	1.38	0.74-2.56
2.11-3.47	18	4099	0.98	0.50-1.92
>3.47	17	3975	1.06	0.54-2.10
Log(CRP)			1.01	0.76-1.36
IL-6 (mg/l)
<1.23	19	4010	1.00	Ref
1.23-1.69	28	3862	1.61	0.89-2.90
1.69-2.47	14	3726	0.83	0.41-1.70
>2.47	14	3597	0.98	0.48-1.98
Log(IL-6)			0.84	0.54-1.29

¹Excluding individuals with baseline CRP >10 mg/l

²Adjusted for age, race, enrollment period, diabetes status, current NSAID use, and clinic